Serum vitamin d levels are independently associated with severity of coronary artery disease

Journal of Investigative Medicine

Volumn 60, Issue 6, 2012, Pages 869-873

  Akin, Fatih ^a   Ayça, Burak ^a   Köse, Nuri ^b   Duran, Mustafa ^a   Sari, Mustafa ^c   Uysal, Onur Kadir ^a   Karakukcu, Cigdem ^a   Arinc, Huseyin ^a   Covic, Adrian ^d   Goldsmith, David ^e   Okçün, Baris ^f   Kanbay, Mehmet ^a  

^a Kayseri Education and Research Hospital ^*  (Turkey)

^b Yücelen Hospital   (Turkey)

^c HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^d GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^f ISTANBUL UNIVERSITY   (Turkey)

Author keywords

25 hydroxyvitamin D; C reactive protein; Coronary artery disease; Inflammatory markers; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; DEMOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; VITAMIN D;

EID: 84864582605     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31825457cb     Document Type: Article

References (38)

1. Norman AW, Bouillon R, Whiting SJ, et al. 13th workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol. 2007;103:204-205.
2. Melamed ML, Muntner P, Michos ED, et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol. 2008;28:1179-1185.
3. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340-1349.
4. Schierbeck LL, Jensen TS, Bang U, et al. Parathyroid hormone and vitamin DVmarkers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail. 2011;13:626-632.
5. Tarcin O, Yavuz DG, Ozben B, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab. 2009;94:4023-4030.
6. Sugden JA, Davies JI, Witham MD, et al. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008;25:320-325.
7. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97:93-101.
8. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
9. Gensini GG. Coronary Arteriogaphy. Mount Kisco, NY: Futura Publishing Co; 1975.
10. Lai H, Fishman EK, Gerstenblith G, et al. Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users. Int J Cardiol. 2011 Feb 2. [Epub ahead of print].
11. Carthy EP, Yamashita W, Hsu A, et al. 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension. 1989;13:954-959.
12. Shioi A, Katagi M, Okuno Y, et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res. 2002;91:9-16.
13. Nibbelink KA, Tishkoff DX, Hershey SD, et al. 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol. 2007;103:533-537.
14. Merke J, Milde P, Lewicka S, et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest. 1989;83:1903-1915.
15. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25 dihydroxyvitamin D3 (calcitriol). J Clin Invest. 1984;74:1451-1455.
16. Wakasugi M, Noguchi T, Inoue M, et al. Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins. 1991;42:127-136.
17. Zehnder D, Bland R, Chana RS, et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol. 2002;13:621-629.
18. Al Mheid I, Patel R, Murrow J, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol. 2011;58:186-192.
19. Carrelli AL, Walker MD, Lowe H, et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke. 2008;39:2611-2613.
20. Reis JP, von Mühlen D, Michos ED, et al. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis. 2009;207:585-590.
21. Chitalia N, Recio-Mayoral A, Kaski JC, et al. Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis. 2012;220:265-268.
22. Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017-2029.
23. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229-238.
24. Oh J, Weng S, Felton SK, et al. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation. 2009;120:687-698.
25. Honye J, Mahon DJ, Jain A, et al. Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation. 1992;85:1012-1025.
26. Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation. 1997;96:1755-1760.
27. Doherty TM, Tang W, Dascalos S, et al. Ethnic origin and serum levels of 1 alpha, 25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation. 1997;96:1477-1481.
28. Arad Y, Spadaro LA, Roth M, et al. Serum concentration of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study. Coron Artery Dis. 1998;9:513-518.
29. Michos ED, Streeten EA, Ryan KA, et al. Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order Amish. Calcif Tissue Int. 2009;84:195-202.
30. de Boer IH, Kestenbaum B, Shoben AB, et al. 25 hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol. 2009;20:1805-1812.
31. Jablonski KL, Chonchol M, Pierce GL, et al. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension. 2011;57:63-69.
32. Wasse H, Cardarelli F, De Staercke C, et al. 25-Hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-sectional study of African American ESRD patients. BMC Nephrol. 2011;12:24.
33. Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the Continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol. 2012;109:226-230.
34. Shea MK, Booth SL, Massaro JM, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol. 2008;167:313-320.
35. Bjorkman MP, Sorva AJ, Tilvis RS. C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin D supplementation trial. J Nutr Health Aging. 2009;13:435-439.
36. Empana JP, Canoui-Poitrine F, Luc G, et al. PRIME Study Group. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study. Eur Heart J. 2008;29:1966-1974.
37. Oudshoorn C, van der Cammen TJ, McMurdo ME, et al. Ageing and vitamin D deficiency: effects on calcium homeostasis and considerations for vitamin D supplementation. Br J Nutr. 2009;101:1597-1606.
38. Valdivielso JM, Coll B, Fernandez E. Vitamin D and the vasculature: can we teach an old drug new tricks? Expert Opin Ther Targets. 2009;13:29-38.